Ramy Saleh, Associate Professor of Medical Oncology and Co-Director of the JAX Adolescent and Young Adult (AYA) Program at McGill University Health Centre, shared a post on LinkedIn:
“Bucket list moment for me
Publishing in The Lancet – one of the most prestigious medical journals in the world and with the highest impact factor – has always been a dream.
Proud to be part of an incredible international effort bringing pimicotinib to patients with a rare tumor (TGCT) who urgently need new treatment options.
Grateful for the support of the McGill University Health Centre, and for the patients and teams who make clinical research possible.”
Title: Pimicotinib versus placebo for tenosynovial giant cell tumour (MANEUVER): an international, randomised, placebo-controlled, phase 3 trial
Authors: Prof Hairong Xu, Prof Xiaohui Niu, Prof Vinod Ravi, Javier Martin-Broto, Albiruni Abdul Razak, Prof Ramy Saleh, Yong Zhou, Prof Jingnan Shen, Prof Tang Liu, Kamlesh Kumar Sankhala, César Serrano, Silvia Stacchiotti, Jing Wang, Giacomo G Baldi, Yi Feng, Yingqi Hua, Tao Li, Prof Piotr Rutkowski, Xiaojing Zhang, Gabriel Tinoco, Qingping Zou, Boyao Shan, Xiangyu Zhu, Prof Hans Gelderblom
Other articles from The Lancet on OncoDaily.